Lung Cancer – China Cancer Help

NON-SMALL CELL & SMALL CELL LUNG CANCER

Advanced Lung Cancer Care in China

Lung cancer requires swift, precise treatment tailored to the tumor’s genetic makeup. China’s national cancer hospitals treat the largest number of lung cancer patients globally. This massive experience has led to world-class robotic surgeries that save healthy lung tissue, gentle particle radiation that protects the heart, and immediate access to the latest targeted pills and immune therapies.

ADVANCED TREATMENT OPTIONS

Key Lung Cancer Treatments

Advanced targeted therapies, robotic keyhole surgeries, and pinpoint proton & carbon ion radiation.

Proton & Carbon Ion Radiation

Ultra-precise particle radiation that stops exactly inside the tumor, killing cancer cells while sparing the heart and healthy surrounding lung tissue.

Learn More

Targeted Pills & Bispecifics

Rapid access to next-generation targeted medications and dual-action immune antibodies designed to overcome drug resistance when earlier treatments stop working.

Learn More

Robotic Keyhole Surgery

Gentle robotic surgery through tiny incisions that safely removes the tumor while preserving maximum breathing capacity and speeding recovery.

Learn More

WHY CHOOSE US

Why Choose China for Lung Cancer

A specialized clinical continuum connecting international lung cancer patients directly with China's national thoracic centers.

China’s designated National Cancer Centers treat the world’s highest annual volume of complex thoracic malignancies. This immense clinical experience translates into exceptional surgical radicality, groundbreaking multi-target clinical trials, and early clinical availability of next-generation EGFR/ALK inhibitors and novel PD-1 bispecific antibodies (such as Ivonescimab) that show superior progression-free survival in advanced lung cancer.

Before traveling, your pathology reports, imaging scans, and molecular NGS panels are evaluated remotely by senior thoracic surgeons, pulmonologists, and particle radiation physicists. Every hospital service is billed transparently at public institution rates with no third-party markups, supported by dedicated bilingual medical coordinators throughout your hospital stay.

HOW IT WORKS

4 Steps to Treatment in China

A simple, step-by-step process from initial record review to your arrival and treatment in China.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international patients considering care in China.

01. Can international patients access next-generation targeted pills in China?

Yes. China has rapid approval pathways for third- and fourth-generation EGFR, ALK, KRAS, and ROS1 inhibitors, as well as novel dual-action bispecific antibodies.

02. How does proton or carbon ion radiation help lung cancer?

Particle radiation stops precisely inside the tumor without exiting behind it, protecting delicate heart muscle, the esophagus, and uninvolved lung tissue from unnecessary radiation.

03. Can inoperable lung tumors be converted to operable?

Yes. Neoadjuvant combinations of targeted therapy or immunotherapy with chemotherapy frequently shrink large tumors, allowing surgeons to perform successful minimally invasive removal.

04. How quickly can a medical evaluation take place?

Initial remote case reviews by multidisciplinary thoracic tumor boards are completed within 48 hours upon receipt of digital CT/PET scans and pathology reports.

CONFIDENTIAL CASE EVALUATION

Start with a Confidential Clinical Case Review

Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.

✓ Free initial triage • ✓ Direct specialist coordination • ✓ 100% Confidential